Chung Shan Medical University
Taichung, 40201, Taiwan
NCT Number: NCT04643613
Many studies (including ASPEN/ESPEN) have demonstrated that balanced diet formula rich in omega 3 fatty acids (ω-3 FA), fibers, protein as well as mineral, vitamins (trace elements) are essential for cancer patients to improve health status and tolerability of chemotherapy. Hence, the present multi-centered, randomized clinical trial was framed to evaluate the efficacy of ready to use balanced nutritional formula-PCNF (rich in ω-3 FA, fibers, MTC, BCAA, and micro-nutrients), in various cancer patient by checking calorie intake and overall health status through assessing various anthropometric and biochemical parameters especially total proteins, pre-albumin, and transferrin.
Looking for future studies?
Notify Me55 year–84 year
All sexes
Interventional
Not applicable
Taichung, 40201, Taiwan
Many studies (including ASPEN/ESPEN) have demonstrated that balanced diet formula rich in omega 3 fatty acids (ω-3 FA), fibers, protein as well as mineral, vitamins (trace elements) are essential for cancer patients to improve health status and tolerability of chemotherapy. Hence, oncologic nutritionist strongly recommends cancer patients (with cachexia) to consume a diet rich in protein and dietary fibers along with balanced essential micronutrients like vitamins and minerals (Van Norren et al., 2009; Yeh et al., 2013). From the above statement, it cleared that nutritional support is a crucial aspect of multi-modal cancer care, by improving the overall health status by suppressing various adverse events as well as enhance treatment regimen for a speedy recovery. Hence, the present multi-centered, randomized clinical trial was framed to evaluate the efficacy of ready to use balanced nutritional formula-PCNF (rich in ω-3 FA, fibers, MTC, BCAA, and micro-nutrients), in various cancer patient by checking calorie intake and overall health status through assessing various anthropometric and biochemical parameters especially total proteins, pre-albumin, and transferrin.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PCNF (237 mL/Pack) for 5-6 times/day via bolus NG tube feeding for 12 weeks
Other names: Protison
Time frame: 12 weeks
The mean value of calorie intake (energy) were significantly increased in PCNF supplemented subjects
Time frame: 12 weeks
BMI were markedly improved in PCNF intook subjects
Time frame: 12 weeks
Protein nutritional assessment index (total protein, pre-albumin , and transferrin) were significantly improved
Time frame: 12 weeks
No significant changes in any of the glycemic indices or lipid profile PCNF groups
Chung Shan Medical University
Other
Role of Ready to Drink Nutritional Formula (Protison Enriched With ω-3 FA and BCAA) Supplemented by Nasogastric Tube Feeding in Various Cancer Patients: A Randomized Clinical Trial
Acronym: Protison
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07167082
Atrophy, Body Weight
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT04585841
Appetitive Behavior, Behavior
Roskilde, Denmark
View Trial DetailsNCT00472940
Body Weight, Body Weight Changes
Houston, Texas, United States
View Trial DetailsNCT00477919
Adenocarcinoma, Adenoma
Basel, Switzerland
View Trial Details